Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Connecticut Innovations
AddedFeb 13, 2024
UpdatedJul 16, 2026
Connecticut Innovations

Connecticut Innovations

Operating

Connecticut Innovations: A Hartford-based venture capital firm investing in tech, healthcare, and pharmaceuticals.

Location
Rocky Hill, CT, US
Founded
1989
Firm
Compare
Portfolio
Employees
Website

Connecticut Innovations is a Hartford-based venture capital firm that focuses on investing in technology, healthcare, and pharmaceutical sectors. The firm typically invests in early-stage companies, including seed and Series A rounds, with a diverse portfolio spanning hardware, healthcare devices, life sciences, and pharmaceuticals. Their investment funds include the ClimateTech Fund, Future Fund, and Connecticut Bioscience Innovation Fund, which provide capital and strategic support to early-stage and growth companies.

Notable portfolio companies include Biohaven Pharmaceuticals, Arvinas, Budderfly, and Cybrexa. The firm is led by key decision-makers who bring extensive industry experience and a commitment to fostering innovation within Connecticut. Connecticut Innovations offers unique value-add services such as strategic guidance, networking opportunities, and access to additional funding resources to help portfolio companies scale efficiently.

Connecticut Innovations - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments208
Current Portfolio Count147
Total Portfolio Exits5

Top Investment Stages

Seed77 (41.2%)
Series A49 (26.2%)
Series Unknown38 (20.3%)
Series B12 (6.4%)
Convertible Note11 (5.9%)

Stage Mix

Seed 41%Series A 26%Series Unknown 20%Series B 6%Convertible Note 6%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Nest Collaborative logo

Nest Collaborative

Vytyl Health Management logo

Vytyl Health Management

IntelliBoard logo

IntelliBoard

Cambium Carbon logo

Cambium Carbon

Summer logo

Summer

Slooh logo

Slooh

Anonybit logo

Anonybit

Modifi Bio logo

Modifi Bio

Raise Green logo

Raise Green

Oova logo

Oova

Driver logo

Driver

2045 Studio logo

2045 Studio

Inbox Health logo

Inbox Health

Bright Feeds logo

Bright Feeds

Bags logo

Bags

Peer Robotics logo

Peer Robotics

Aceiss logo

Aceiss

Noteworthy AI logo

Noteworthy AI

FinTron logo

FinTron

Plazmod Technologies logo

Plazmod Technologies

Upswing Health logo

Upswing Health

Encapsulate logo

Encapsulate

CoreChain Technologies logo

CoreChain Technologies

Covr Financial Technologies logo

Covr Financial Technologies

1906 logo

1906

Connecticut Innovations - Classification

Also Known As
  • Connecticut Innovations, Incorporated
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end